Life threatening intra-abdominal sepsis in patients on anti-TNF- therapy
- 1 April 2006
- Vol. 55 (4), 590-591
- https://doi.org/10.1136/gut.2005.085449
Abstract
A 60 year old male with psoriatic arthritis resistant to treatment had benefited from etanercept for six months. In rheumatology outpatients he complained of a two week history of abdominal pain. On examination he was tender in the left upper quadrant with a palpable mass. A contrast enhanced computed …Keywords
This publication has 6 references indexed in Scilit:
- Update on the British Society for Rheumatology guidelines for prescribing TNF blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001)Rheumatology, 2005
- Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active‐surveillance reportArthritis & Rheumatism, 2003
- Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapyRheumatology, 2003
- Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor α–neutralizing agentsArthritis & Rheumatism, 2003
- Life‐threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanerceptArthritis & Rheumatism, 2002
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001